Legend Biotech (LEGN) Invested Capital (2019 - 2025)
Legend Biotech (LEGN) posted Invested Capital of $1.0 billion for Q1 2025, down 21.14% on a QoQ basis from $1.3 billion in Q4 2024, and down 12.57% year-over-year from $1.2 billion in Q1 2024.
Legend Biotech (LEGN) has 7 years of Invested Capital data on file, last reported at $1.0 billion in Q1 2025.
- In Q1 2025, Invested Capital fell 12.57% year-over-year to $1.0 billion; the TTM figure through Mar 2025 stood at $1.0 billion (down 12.57% YoY), while the FY2024 annual figure was $1.3 billion, down 14.04% from the prior year.
- Invested Capital eased to $1.0 billion in Q1 2025, from $1.3 billion in the prior quarter.
- Across five years, Invested Capital topped out at $1.5 billion in Q4 2023 and bottomed at $206451.0 in Q1 2021.
- A 5-year average of $909.2 million and a median of $1.1 billion in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital jumped 358900.44% — and 2024, when it decreased 17.63%.
- Year by year, Invested Capital stood at $878.7 million in 2021, then soared by 30.11% to $1.1 billion in 2022, then jumped by 31.32% to $1.5 billion in 2023, then declined by 14.04% to $1.3 billion in 2024, then slipped by 21.14% to $1.0 billion in 2025.
- The last three Invested Capital figures came in at $1.0 billion (Q1 2025), $1.3 billion (Q4 2024), and $1.1 billion (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.29 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.50 Bn |
| Sep 30, 2023 | 1.34 Bn |
| Jun 30, 2023 | 1.41 Bn |
| Mar 31, 2023 | 653.16 Mn |
| Dec 31, 2022 | 1.14 Bn |
| Mar 31, 2022 | 741.16 Mn |
| Dec 31, 2021 | 878.67 Mn |
| Sep 30, 2021 | 225.87 Mn |
| Jun 30, 2021 | 339,919.00 |
| Mar 31, 2021 | 206,451.00 |
| Dec 31, 2020 | 601.14 Mn |
| Sep 30, 2020 | 334,900.00 |
| Jun 30, 2020 | 401,001.00 |
| Dec 31, 2019 | 157.41 Mn |